相似文献
1
Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme.
Cancer Res. 2008 Nov 1;68(21):8657-60. doi: 10.1158/0008-5472.CAN-08-2084.
2
Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Clin Cancer Res. 2011 Jun 1;17(11):3771-82. doi: 10.1158/1078-0432.CCR-10-2393. Epub 2011 Jan 24.
3
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):409-15. doi: 10.1001/archotol.132.4.409.
4
Deletion of RD enhancer: A novel mutation to "inactivate" the INK4-ARF locus.
DNA Repair (Amst). 2017 Sep;57:50-55. doi: 10.1016/j.dnarep.2017.06.027. Epub 2017 Jun 24.
5
Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells.
Mol Carcinog. 2014 Mar;53(3):211-8. doi: 10.1002/mc.21965. Epub 2012 Oct 12.
6
Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Am J Pathol. 2001 Aug;159(2):661-9. doi: 10.1016/S0002-9440(10)61737-3.
7
Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.
Acta Neuropathol. 2001 Aug;102(2):167-74. doi: 10.1007/s004010100374.
8
Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.
Cancer Res. 2008 Apr 15;68(8):2564-9. doi: 10.1158/0008-5472.CAN-07-6388. Epub 2008 Apr 1.
9
Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Atherosclerosis. 2011 Feb;214(2):264-70. doi: 10.1016/j.atherosclerosis.2010.06.029. Epub 2010 Jun 23.
10
Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Hum Pathol. 2009 Jun;40(6):817-26. doi: 10.1016/j.humpath.2008.11.002. Epub 2009 Feb 5.
引用本文的文献
1
Genomic, epigenomic and transcriptomic landscape of glioblastoma.
Metab Brain Dis. 2024 Dec;39(8):1591-1611. doi: 10.1007/s11011-024-01414-8. Epub 2024 Aug 24.
2
Glioblastoma Therapy: Past, Present and Future.
Int J Mol Sci. 2024 Feb 21;25(5):2529. doi: 10.3390/ijms25052529.
3
Investigation of the Effect of 5-Aza-2'-Deoxycytidine in Comparison to and in Combination with Trichostatin A on , , Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer Caco-2 Cell Line.
Int J Prev Med. 2021 Jun 25;12:64. doi: 10.4103/ijpvm.IJPVM_11_20. eCollection 2021.
4
Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models.
Cell Death Discov. 2021 Mar 15;7(1):54. doi: 10.1038/s41420-021-00423-1.
5
Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology.
Cell Mol Life Sci. 2021 Feb;78(4):1329-1354. doi: 10.1007/s00018-020-03664-y. Epub 2020 Oct 19.
6
Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue.
PLoS One. 2020 Jul 7;15(7):e0234986. doi: 10.1371/journal.pone.0234986. eCollection 2020.
7
Replication stress triggers microsatellite destabilization and hypermutation leading to clonal expansion in vitro.
Nat Commun. 2019 Sep 2;10(1):3925. doi: 10.1038/s41467-019-11760-2.
8
Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
PLoS One. 2018 Jul 30;13(7):e0195070. doi: 10.1371/journal.pone.0195070. eCollection 2018.
9
Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review.
Cell Prolif. 2018 Feb;51(1). doi: 10.1111/cpr.12422. Epub 2017 Dec 10.
10
Inactivation of 15 in chronic arsenic poisoning cases.
Toxicol Rep. 2014 Sep 17;1:692-698. doi: 10.1016/j.toxrep.2014.08.007. eCollection 2014.
本文引用的文献
1
Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development.
Cancer Cell. 2008 Apr;13(4):355-64. doi: 10.1016/j.ccr.2008.02.010.
2
Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.
Cancer Res. 2008 Apr 15;68(8):2564-9. doi: 10.1158/0008-5472.CAN-07-6388. Epub 2008 Apr 1.
3
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
Genes Dev. 2007 Nov 1;21(21):2683-710. doi: 10.1101/gad.1596707.
4
Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Cancer Res. 2007 May 15;67(10):4732-41. doi: 10.1158/0008-5472.CAN-06-3437.
5
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.
Cell Div. 2006 Oct 18;1:23. doi: 10.1186/1747-1028-1-23.
6
N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11579-83. doi: 10.1073/pnas.0604727103. Epub 2006 Jul 24.
7
p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control.
Mol Cell Biol. 2006 Jun;26(12):4564-76. doi: 10.1128/MCB.00266-06.
8
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.
Genes Dev. 2005 Nov 15;19(22):2656-67. doi: 10.1101/gad.1368605. Epub 2005 Oct 31.
9
Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.
Cancer Res. 2003 Sep 1;63(17):5420-7.
10
Tumor suppression by Ink4a-Arf: progress and puzzles.
Curr Opin Genet Dev. 2003 Feb;13(1):77-83. doi: 10.1016/s0959-437x(02)00013-8.
Zotero 插件